Global Viral Vectors and Plasmid DNA Manufacturing Market is anticipated to reach US$2,381.5 Million in 2031: Visiongain Research Inc
March 23, 2022 10:00 ET
|
Visiongain Ltd
Visiongain has published a new report on “Viral Vectors and Plasmid DNA Manufacturing Market 2021-2031”. Forecasts by Vector Type (Adenovirus, Retrovirus, Plasmid DNA, AAV, Lentivirus,...
Viral Vectors and Plasmid DNA Manufacturing Market size worth $ 1,866.90 Million, Globally, by 2028 at 15.40% CAGR: Verified Market Research®
October 26, 2021 11:15 ET
|
Verified Market Research
Jersey City, New Jersey, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Viral Vectors and Plasmid DNA Manufacturing Market” By Product Type (Viral Vectors,...
Viral Vectors & Plasmid DNA Manufacturing Market to Hit US$ 1.3 Bn by 2027
August 19, 2021 11:00 ET
|
Precedence Research
Ottawa, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Ottawa, Aug 19, 2021 (GLOBE NEWSWIRE) – According to Precedence Research, the viral vectors & plasmid DNA manufacturing market size was valued at US$...
Viral Vectors and Plasmid DNA Manufacturing Market Worth US$2,381.5 Million by 2031: Visiongain Research Inc.
July 07, 2021 09:00 ET
|
Visiongain Ltd
Visiongain has published a new report on “Viral Vectors and Plasmid DNA Manufacturing Market 2021-2031”. Forecasts by Vector Type (Adenovirus, Retrovirus, Plasmid DNA, AAV, Lentivirus, Others),...
Viral Vectors and Plasmid DNA Manufacturing Market to Garner $4.97 Billion by 2027: AMR
October 13, 2020 09:38 ET
|
Allied Market Research
Portland, OR, Oct. 13, 2020 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global viral vectors and plasmid DNA manufacturing market generated $918.37 million in...
Viral Vectors & Plasmid DNA Manufacturing Market Size is Expanding over US$ 1.3 Bn by 2027
September 30, 2020 11:45 ET
|
Precedence Research
The global viral vectors & plasmid DNA manufacturing market size is expanding over US$ 1.3 billion by 2027, according to new study by Precedence Research. OTTAWA, Sept. 30, 2020 (GLOBE...
Toronto centre solving cell manufacturing challenges to benefit patients and global industry
June 02, 2020 06:00 ET
|
Centre for Commercialization of Regenerative Medicine (CCRM)
TORONTO and MARLBOROUGH, Mass., June 02, 2020 (GLOBE NEWSWIRE) -- With Health Canada and the Food and Drug Administration beginning to approve and reimburse cell and gene therapies in significant...